Abstract
Systemic infections can yield distinct outcomes in different tissues. In mice, intravenous inoculation of E. coli leads to bacterial replication within liver abscesses while other organs such as the spleen largely clear the pathogen. Abscesses are macroscopic necrotic regions that comprise the vast majority of the bacterial burden in the animal, yet little is known about the processes underlying their formation. Here, we characterize E. coli liver abscesses and identify host determinants of abscess susceptibility. Spatial transcriptomics revealed that liver abscesses are associated with heterogenous immune cell clusters comprised of macrophages, neutrophils, dendritic cells, innate lymphoid cells, and T-cells that surround necrotic regions of the liver. Susceptibility to liver abscesses is heightened in the C57BL/6 lineage, particularly in C57BL/6N females. Backcross analyses demonstrated that abscess susceptibility is a polygenic trait inherited in a sex-dependent manner without direct linkage to sex chromosomes. As early as one day post infection, the magnitude of E. coli replication in the liver distinguishes abscess-susceptible and abscess-resistant strains of mice, suggesting that the immune pathways that regulate abscess formation are induced within hours. We characterized the early hepatic response with single-cell RNA sequencing and found that mice with reduced activation of early inflammatory responses, such as those lacking the LPS receptor TLR4, are resistant to abscess formation. Experiments with barcoded E. coli revealed that TLR4 mediates a tradeoff between abscess formation and bacterial clearance. Together, our findings define hallmarks of E. coli liver abscess formation and suggest that hyperactivation of the hepatic innate immune response drives liver abscess susceptibility.
Introduction
Bloodstream infections are a leading cause of human mortality (1). Although bacteria routinely breach epithelial barriers and enter systemic circulation, most of these events do not cause disease, in large part because innate immune cells within the liver, spleen, and other organs sequester and kill circulating bacteria (2). However, many microorganisms encode factors that facilitate evasion of or resistance to these host defenses. Gram-negative species pose an especially challenging threat to the healthcare system due to the continued emergence of antimicrobial resistance (3).
The Gram-negative bacterium Escherichia coli is among the leading causes of human bloodstream infections (4). Due to the systemic nature of these infections, resolution of infection requires most organs in the host to mount an immune response, and these responses vary across tissues. Consequently, systemic infections caused by Extraintestinal Pathogenic E. coli (ExPEC) can manifest a wide range of tissue-specific clinical syndromes in which bacterial factors, such as pili and siderophores, enable the pathogen to counteract host defenses and survive and replicate (5–7).
Ultimately, the interplay between these pathogen factors and host defenses leads to tissue-specific pathology (8). Deciphering why some tissues are permissive to pathogen growth while others are restrictive is critical for understanding the mechanistic underpinnings of infection outcomes across host tissues. Existing models of systemic ExPEC infection yield either rapid sepsis and death within hours (9, 10) or clearance of bacteria from the animal (11, 12). An animal model that lies in between these two extremes, where bacteria replicate and survive within the host for extended time periods, would deepen our understanding of pathogen and host factors that influence the outcome of extraintestinal E. coli infections.
We previously observed that mice inoculated intravenously with ExPEC developed visibly apparent abscesses specifically in the liver (15). By using a library of bacteria that possessed ~1000 unique DNA barcodes at a neutral locus and the STAMPR computational pipeline (13), we found that abscesses coincide with the expansion of ~10 clones that replicate to ~107 colony forming units (CFU) (14). Although abscesses in the liver represent the predominant site of E. coli replication in the animal, the mechanisms that underlie E. coli abscess formation are unknown. In general, animal models of Gram-negative liver infections have received little attention. Since E. coli is a leading cause of human liver abscesses and abscesses are often fatal if left untreated (15), a tractable animal model is valuable for expanding understanding of tissue specific immune responses and for the development of therapeutic interventions.
In this study, we characterize the cellular composition, genetics, kinetics, and immunology of E. coli-induced liver abscesses in mice. Liver abscesses are dependent on mouse genotype and are inherited in a sex-dependent manner without direct linkage to sex chromosomes. Although abscesses require several days to fully develop, the pathways that confer susceptibility to abscess formation are engaged within hours, the timescale in which massive numbers of innate immune cells are recruited to the liver and proinflammatory cytokines are induced. Mice that are resistant to abscess formation are defective for both Gr1+ inflammatory cell recruitment and proinflammatory cytokine production in the hours following inoculation. These defects are phenocopied in mice lacking the LPS receptor TLR4, which are comparably resistant to abscess formation. However, in the absence of TLR4, fewer E. coli are eliminated by host restriction processes, suggesting that TLR4 governs a tradeoff between pathogen clearance and replication. We propose that E. coli liver abscesses result when tissue damage from inflammation provides a niche for pathogen replication. Taken together, our findings reveal important characteristics of a mouse model for E. coli-induced liver abscesses and establish a tractable platform to investigate tissue-specific innate immunity.
Results
Phenotypic characterization of E. coli-induced liver abscesses
Female C57BL/6J (B6J) mice were inoculated intravenously (IV) with 5×106 CFU of a barcoded E. coli library (CHS7-STAMP, derived from extraintestinal pathogenic strain CFT073 (16)) and liver bacterial burden was enumerated at 5 days post inoculation (dpi). Consistent with our previous study (14), we found that approximately half of the mice developed visible liver abscesses (approximately 0.5 – 2 mm2) with correspondingly very high bacterial burdens (Figure 1); animals with abscesses had 100,000 times greater CFU than those that did not. Occasionally, animals with very low CFU had very small white lesions. In this study, abscesses are defined as the co-occurrence of visible white lesions and a hepatic CFU burden of at least 104. Hematoxylin and Eosin (H&E) staining revealed that the abscess core primarily consists of necrotic hepatocytes surrounded by mixed inflammatory cells resembling macrophages and neutrophils (Figure 1, Figure S1A). Despite the apparent tissue damage (Figure 1, Figure S1A), serum levels of alanine aminotransferase (ALT), which is released from damaged hepatocytes (17), were similar in animals that possessed or lacked abscesses (Figure S1B).
Unlike B6J females, BALB/cJ, CBA/J, and C3H/HeJ females were entirely resistant to abscess formation (Figure 2A). Surprisingly, female C57BL/6NJ (B6N) mice developed abscesses at even higher frequencies than B6J females. Increased abscess frequency in B6N relative to B6J was also observed at a 10-fold lower inoculum size, where B6J mice do not develop abscesses (Figure 2B). B6N and B6J diverged from the ancestral C57BL/6 strain in 1951 following their transfer to the National Institutes of Health (B6N) from Jackson Labs (B6J) and differ by ~10,000 SNPs as of 2013 (18). These data suggest that the allele(s) conferring abscess susceptibility is present in the C57BL/6 lineage, and one or more mutations have occurred within this lineage that further distinguish B6N and B6J.
Abscess susceptibility did not correlate with other clinical outcomes. B6N (susceptible) females lost weight at 1 dpi but then their weight remained stable at 5 dpi, when abscesses have fully formed (Figure S1C). B6N females also survived up to 30 dpi, at which point abscesses were no longer present and there were <104 CFU in livers (Figure 2C). Therefore, E. coli liver abscesses do not cause mortality and are eventually cleared in mice. No E. coli CFU were detectable in female BALB/cJ (resistant) at 30 dpi. Abscesses did not occur in B6N females when the route of inoculation was changed from IV to intraperitoneal injection, suggesting that immediate pathogen capture by the liver may be important for abscess formation (Figure 2D). Abscesses also formed in B6N females following IV inoculation of nonpathogenic E. coli strain Nissle (19), and to a lesser extent with laboratory strain MG1655, suggesting that abscess induction is not a unique property of the bacterial strain used in this study (Figure 2E).
To gain further insight into the identity and function of the immune cells that surround the necrotic zone within abscesses, we performed spatial transcriptomics with MERFISH (Multiplexed Error Robust Fluorescence In Situ Hybridization) a probe-based hybridization technique (20), using the MERSCOPE instrument (Figure 3, Figure S2–S5). MERFISH enables simultaneous identification of hundreds of user-specified RNA molecules in situ. We selected transcripts corresponding to specific cell types identified in the Liver Cell Atlas (21). In uninfected B6J animals, hepatocyte zonation markers (Cyp2e1 and Cyp2f2) clearly demarcated differential expression across hepatocytes, indicating that this approach is useful for analysis of liver tissue. By 3 dpi, substantially reduced RNA signal was observed within abscess cores, which lacked hepatocyte zonation markers presumably due to local necrosis and RNA degradation (Figure 3, Figure S2–S5). On the border of and within 5 dpi abscesses, enrichment of transcripts corresponding to migratory dendritic cells (Cacnb3), neutrophils (S100a8/9) and macrophages (Adgre1) were detected. Transcripts corresponding to T cells (Cd4, Cd3g, Cd3e, Cd3d) and NK cells/ILC1s (Klrb1b) cells were also detected in these locations but at lower abundances. The assembly of similar, smaller immune cell clusters was also seen associated with smaller zones of RNA degradation at 3 dpi. Some immune cell clusters lacked RNA degradation altogether and may represent resolved or early-stage abscesses (Figure S3). Importantly, these cell clusters were absent in uninfected mice (Figure 3, Figure S2) and were enriched for lysozyme (Lyz2), nitric oxide synthase (Nos2), and cytochrome b oxidase (Cybb), markers associated with inflammatory responses (Figure 3, Figure S2–S5). These results indicate that immune cell clusters associated with liver abscesses are heterogeneous and express many known inflammatory markers.
Abscess susceptibility is a polygenic trait with sex-influenced inheritance
To begin to identify host factors that regulate liver abscess formation, we first determined the inheritance pattern of the abscess susceptibility trait. Importantly, both sexes of BALB/cJ mice were resistant to abscesses, while both sexes of B6J mice were sensitive, with slightly heightened sensitivity in B6J males (Figure 4A). The F1 offspring of female BALB/cJ (resistant) and male B6J mice (sensitive), known as CB6F1/J, were challenged intravenously with E. coli and CFU burden and the frequency of liver abscesses were assessed 5 dpi. Surprisingly, only F1 female mice inherited the abscess susceptibility trait, while F1 males were resistant (Figure 4B). Since male CB6F1/J mice lack a B6J X-chromosome, and female CB6F1/J mice have 1 copy each of the BALB/cJ and B6J X-chromosome, these data initially raised the possibility that abscess susceptibility is X-linked in B6J. In this scenario, the B6J X-chromosome possesses an abscess susceptibility allele, and CB6F1/J males lack this allele. To experimentally test if an abscess susceptibility allele is X-linked, we crossed female B6J mice with male BALB/cJ mice (reverse sexes from previous cross). In the F1 offspring (known as B6CF1), males possess a B6J X-chromosome, whereas females possess both BALB/cJ and B6J alleles. Surprisingly, B6CF1 males and females phenocopied CB6F1/J mice; males were resistant, and females were susceptible (Figure 4B). These data reveal that abscess susceptibility is not sex-chromosome linked in BALB/cJ x B6J F1 animals but is influenced by sex. However, the influence of sex on susceptibility seems to be modified by genetic background. We found that inbred B6N males were more resistant to abscess formation than B6N females (Figure 4A). Given the differences in abscess frequency between B6J and B6N mice, we assessed whether the inheritance pattern in BALB/cJ X B6N F1 animals was distinct from that observed in BALB/cJ X B6J F1 mice. However, we again found that F1 females were partially sensitive, and males were resistant regardless of the sex of the parents, similar to the F1 offspring of B6J and BALB/cJ (Figure 4C).
These results cannot be explained by maternal inheritance of mitochondria; CB6F1/J males and B6CF1 males both differ in mitochondrial alleles but possess identical phenotypes. Furthermore, abscess susceptibility is not directly conferred by the Y-chromosome, since females are generally more sensitive, except in inbred B6J. The BALB/cJ Y-chromosome is also unlikely to possess a unique, abscess-inhibitory factor, since male F1 offspring are all resistant to abscess formation regardless of Y-chromosome alleles. Collectively, these results support a model where abscess susceptibility is inherited in a recessive manner in males and in an incomplete dominant manner in females, but is not directly linked to the X, Y, or mitochondrial chromosomes.
With the expectation that the abscess susceptibility trait is autosomal, we carried out backcrosses between B6J males and CB6F1/J females, generating N1 backcross offspring (Figure S6A). All N1s are identical for mitochondrial (all BALB/cJ from maternal grandmother) and Y chromosomes (all B6J from father). Among the autosomes, these N1s are ~50% heterozygous and ~50% homozygous for B6J alleles at random loci. Since abscesses are incomplete dominant in females, all N1 females should have a ~50% likelihood of developing abscesses. However, since abscesses are inherited recessively in males, only male mice that are homozygous for the causal B6J allele should be susceptible (~70% likelihood) to abscesses. Thus, we proceeded only with male N1 mice. 153 male N1 mice were analyzed with a genotyping array consisting of ~3000 SNPs that distinguish BALB/cJ and B6J alleles to map the heterozygosity, homozygosity (B6J), or hemizygosity (for X-chromosome) of the N1 genomes. At 8–10 weeks of age, male N1s were infected and abscess frequency and CFU burden were scored at 5 dpi. Importantly, 44% of mice developed abscesses, confirming that introducing B6J alleles into an otherwise resistant background (heterozygous CB6F1/J males) also reintroduces abscess susceptibility (Figure S6B).
At every SNP, we calculated abscess frequencies of homozygous (for B6J) mice relative to abscess frequencies of heterozygous mice, expecting that abscesses would be more likely to form in mice homozygous at the causal allele relative to mice that are heterozygous for the causal allele. Given that N1s consist of mice with both brown and black coats, we verified that this strategy is effective by identifying the agouti locus (which governs coat color). We observed a clear signal for homozygosity in Chr. 2 at the location of the agouti locus in mice with black coats (Figure S6C). However, we observed no such signal when identifying homozygous loci associated with abscess formation (Figure S6D). Since this approach can identify a monogenic trait, we conclude that the abscess susceptibility trait is polygenic. Specifically, B6J males contain at least two loci that are, when homozygous, independently sufficient to confer abscess susceptibility. Abscess susceptibility in heterozygous F1 females suggests that these loci only require one copy to sensitize females to abscess formation.
Bacterial replication and early hepatic responses following infection
The backcross experiments did not lead to the identification of a single genetic locus that distinguishes abscess-susceptible versus abscess-resistant mice. Therefore, we set out to identify phenotypes associated with abscess formation that may distinguish susceptible and resistant mouse strains. Identifying these phenotypes required further knowledge of the kinetics of abscess formation to facilitate distinguishing between pathways that cause abscesses and those that simply respond to the increased bacterial burden associated with abscess formation.
We examined whether female BALB/cJ (resistant), B6J (intermediate-susceptible), and B6N (hyper-susceptible) mice had phenotypically diverged as early as 1 dpi. Indeed, by 1 dpi, total burden was low in BALB/cJ, intermediate in B6J, and high in B6N (Figure 5A). Furthermore, bacterial burden correlated with gross appearance of the liver; even at 1dpi there were prominent white lesions in the livers of B6N female mice that were less abundant in B6J and absent in BALB/cJ animals (Figure 5B). Sequencing the barcode loci to measure the abundance of individual clones confirmed that these differences in CFU correlated with increased replication of a small number of clones, the bacterial hallmark of abscess formation. At 1 dpi BALB/cJ livers lacked replicating clones, while B6J had 1–2 replicating clones, and B6N had ~40 replicating clones (Figure 5C, Figure S7). Bacteria within abscess-susceptible mice therefore have a higher likelihood of undergoing replication early after inoculation, which presumably drives abscess formation. Collectively, these data suggest that the innate immune pathways that underlie abscess-sensitive and resistant phenotypes likely diverge within the first day, when early signs of abscess formation are already apparent, both as visible lesions in the liver and as replication of E. coli clones.
We performed single cell RNA sequencing of liver CD45+ immune cells 4 hours post infection (hpi) to characterize the hepatic immune pathways activated early following infection, but prior to gross liver damage and E. coli replication (14). Because abscesses are dose-dependent in B6J mice (22), we inoculated mice at a range of inoculum sizes, from 0 CFU to 1×107 CFU. UMAP clustering revealed a marked dose-dependent expansion of clusters (1, 3, 2, and 11) that expressed markers corresponding to primarily macrophages and neutrophils (Figure 6AB, Figure S8). The large magnitude of the increase in the abundance of these cell types at this early time strongly suggests that these cells infiltrated into the liver from the blood rather than expanded in situ. These infiltrating innate immune cells share similar gene expression patterns, including the expression of S100a8/9, Lcn2, and Il1b, and cluster together in UMAP space (Figure S8). Other cell types, including B cells, T cells, NK cells, and dendritic cells, did not change in relative abundance (Figure 6CD) but were also responsive to infection. These included the dose-dependent production of interferon gamma (Ifng) by NK/T cells, cytokine and chemokine production from T and B cells (Cxcl1, Cxcl10), and downregulation of growth factor signaling in endothelial cells (Kdr) (Figure S8). Taken together, these findings reveal that innate immune responses in the liver, which include macrophage and neutrophil infiltration and proinflammatory cytokine production, are induced prior to the replication of clones and visible liver damage that distinguish abscess-susceptible and resistant mouse strains. These inflammatory responses are correspondingly diminished at lower inoculum sizes where abscesses are less likely to develop.
Abscess formation requires TLR4
To assess whether infiltrating immune cells directly contribute to abscess formation, we treated mice with an anti-Gr1 antibody, which depletes neutrophils and Ly6C+ monocytes and macrophages (23). However, Anti-Gr1 treatment resulted in 100% mortality by 2 dpi (Figure 7A) suggesting that at least some Gr1+ cell infiltration is required to control infection. We reasoned that a more subtle perturbation was necessary to elucidate the roles of early immune responses in the liver. Since many of the phenotypes observed at 4 hpi are likely induced by LPS stimulation via the LPS receptor Toll-like receptor 4 (TLR4) (24), we examined whether mice lacking TLR4 (in a B6J background) were resistant to abscess formation. Similar to McDonald et al, who found that TLR4KO mice had reduced Gr1+ cell infiltration in the liver following IV LPS administration (25), Gr1+ cells were reduced in the livers of TLR4KO mice after IV E. coli inoculation (Figure 7B). Further, serum levels of Cxcl1, Cxcl10, Il1β, and Tnfα, chemokines and cytokines that are downstream of TLR4 signaling, were reduced in TLR4KO mice at 4 hpi. (Figure 7C). TLR4KO females that were acquired from Jackson laboratories or bred in house failed to form abscesses, while TLR4Het littermate controls were susceptible to abscess formation. However, CFU burden in TLR4KO animals was higher compared to control animals that lacked abscesses (Figure 7D). These results indicate that abscess formation requires TLR4, consistent with the hypothesis that liver abscess susceptibility is driven by overactivation of the immune response.
Since BALB/cJ and TLR4KO B6J mice were both resistant to abscess formation (Figure 3A, 7D), we assessed whether both strains share similarly reduced immune responses compared with wild-type B6J mice at 4 hpi. BALB/cJ mice had reduced Gr1+ immune cell infiltration, comparable to levels observed in TLR4KO mice (Figure 7E). Furthermore, similar low serum levels of Cxcl1, Cxcl10, Il1β, and Tnfα were found in BALB/cJ and TLR4KO B6J mice (Figure 7C and F). Importantly, at 4hpi, no difference in E. coli CFU burden was observed between BALB/cJ, B6J, and B6N mice, confirming that the differential immune response is induced prior to abscess-distinguishing replication (Figure 7G). Thus, at 4 hpi, two abscess-resistant strains of mice (BALB/cJ and TLR4KO) display similarly attenuated immune responses relative to susceptible mice (B6J and B6N). Together, these data suggest that following inoculation, E. coli in the liver signals via TLR4 to promote influx of innate immune cells, which in turn facilitates bacterial replication and development of liver abscesses. Although BALB/cJ mice possess functional TLR4, their early hepatic inflammatory response is likely blunted through other mechanisms.
TLR4 governs a tradeoff between efficient clearance and abscess formation.
B6J females lacking TLR4 had elevated hepatic bacterial burdens compared to WT B6J or TLR4Het littermates that did not form abscesses (Fig 7D). The increase in CFU in TLR4KO animals could be explained by a reduced capacity to clear the inoculum, to control bacterial replication, and/or to control pathogen dissemination between organs. To quantify the extent to which clearance, replication, or dissemination contribute to the increase in burden in TLR4KO animals, we sequenced the barcode loci in E. coli and performed STAMPR analysis. This computational framework quantifies the number of cells from the inoculum that give rise to the population in an organ, known as the founding population (FP). Founders represent the organisms that survived infection bottlenecks, which consist of host factors that eliminate bacteria from the inoculum. A decrease in FP signifies a tightening of the infection bottleneck, and thus an increase in host clearance of the pathogen. The ratio of CFU to FP quantifies the net expansion of each clone; high CFU/FP ratios signify that each founding clone is represented multiple times, which in the absence of substantial dissemination, is due to bacterial replication. Finally, comparison of barcode frequencies between organs yields a genetic distance (GD) metric, where lower GD values indicate increased similarity between samples and therefore suggest increased dissemination.
TLR4KO mice had higher founding populations (Figure 8B) compared to TLR4Het littermates, indicating that TLR4 is required for efficient clearance of the inoculum. TLR4Het animals that developed abscesses had substantially higher CFU/FP ratios than both TLR4KO and TLR4Het animals that did not develop abscesses (Figure 8C). However, when TLR4Het animals that developed abscesses were excluded from the analysis, we found that the TLR4KO mice possessed higher CFU/FP ratios; each clone was more abundant in TLR4KO mice compared to heterozygote littermate (Figure 8C). The higher CFU/FP ratio in TLR4KO mice is driven by increased bacterial replication, since neither TLR4KO and TLR4Het mice substantially shared bacteria between the liver and spleen (Figure 8D). These data together reveal that the increase in CFU in TLR4KO animals is primarily due to a failure of the TLR4 deficient animals to clear the inoculum and their inability to control a subsequent ~1–3 E. coli net cell divisions, but not due to an increase in dissemination. In contrast, TLR4Het animals efficiently clear the inoculum, but surviving E. coli clones are more likely to undergo a net of ~15–20 cell divisions within abscesses. Therefore, TLR4 signaling mediates a tradeoff between liver abscess development and efficient pathogen elimination.
Discussion
Our study identifies molecular and genetic factors that govern tissue-specific liver abscess formation in a mouse model of E. coli systemic infection. In contrast to several other abscess and bacteremia models, mice with E. coli liver abscesses ultimately clear the infection, suggesting that this system will be valuable for understanding mechanisms that lead to abscess clearance as well as formation. Abscesses represent localized regions of hepatic necrosis and marked replication of relatively few E. coli clones (14). Since commensal E. coli can elicit abscess formation and TLR4KO animals do not develop abscesses, we propose that abscesses result from exuberant TLR4-driven immune responses, rather that specific pathogen-derived virulence factors, which drive Staphylococcus aureus-induced renal abscesses (26). Further supporting the hypothesis that host factors primarily drive E. coli liver abscess formation is our observation that sex and mouse genotype govern abscess susceptibility. Relative to susceptible animals, mice that are resistant to abscess formation exhibit reduced Gr1+ immune cell recruitment and reduced proinflammatory cytokine production in the hours following infection, suggesting that early hepatic responses to E. coli may determine whether abscesses form. One to three days following inoculation, heterogeneous inflammatory immune cell clusters form in the liver, coinciding with the replication of a small number of E. coli clones. In the absence of Gr1+ cells, mice succumb to infection before abscesses can develop. However, mice that recruit fewer Gr1+ (BALB/cJ and TLR4KO) do not form abscesses and do not exhibit pathogen clonal expansion. Together our findings suggest that abscesses result from collateral damage caused by infiltrating innate immune cells and their products and that E. coli exploits areas of damaged tissue to replicate more substantially than in the absence of tissue damage (Figure S10). Control of the delicate balance between recruitment of sufficient inflammatory cells to abrogate E. coli replication and limiting damage to normal liver tissue by the inflammatory process appears to be defective in the livers of the C57BL/6 lineage. We speculate that defects in the mechanisms that govern this balance may underlie tissue-specific damage associated with a variety of infections.
Spatial transcriptomics is a powerful emerging approach for mapping the distribution and function of host cells in intact tissue, but to date has had limited application to infection contexts (27). At three and five dpi, we found that abscess cores were marked by a paucity of RNA signal and the absence of hepatic zonation markers, likely indicative of necrosis. Immune cell clusters adjacent to necrotic hepatocytes within abscess were highly heterogenous, consisting of dendritic cells, particularly Cacnb3+ migratory dendritic cells, and other Itgam+ (CD11b) cells, innate lymphoid cells, T cells, neutrophils, monocytes, and macrophages (Figure 3, Figure S4). These immune clusters were enriched for markers of inflammatory responses such as lysozyme (Lyz2) that could contribute to tissue destruction. Unexpectedly, we found a rim of live hepatocytes expressing Cxcl1 surrounding the abscesses by 5 dpi (Figure S4). Analyzing the specific functions of these cells, and how their roles in abscess formation and resolution is regulated by Cxcl1, should be experimentally approachable using CRISPR-based technology to genetically modify hepatocytes in vivo (28)
Single-cell RNA sequencing revealed a dramatic influx of macrophages and neutrophils into the liver four hpi. These two cell types, typically defined by expression of Ly6g (neutrophils) and Adgre1 (F4/80, macrophages), expressed a similar transcriptional program following infection, including S100a8/9, Lcn2, Cxcl2, and Il1b (Figure 6, Figure S8). Therefore, although infection induces infiltration of distinct cell lineages, they express similar genes and may play similar roles in pathogen clearance or abscess formation. We also found that changes in the abundance of immune cell populations and their respective transcriptional outputs was highly responsive to the E. coli dose. For example, a 5×104 dose yielded a larger population of monocytes (cluster 5) relative to macrophages (cluster 1 and 3) (Figure 6), suggesting that higher doses, where a higher macrophage to monocyte ratio was observed, may lead to more efficient macrophage maturation and/or influx. The relative abundances of distinct cell types within the liver and their transcriptional states may be consequential for scaling the clearance capacity with the inoculum size. Distinct components of the innate immune response also scale with dose at different rates. For example, Lcn2 and Il1b transcripts were induced within infiltrating cells at the lowest dose tested, but expression of Cxcl1 and Ifng scaled more gradually and within distinct cell types (Figure S8). Together these observations uncover the key role of infectious dose in control of consequential immune responses, which likely modulate infection outcomes (22).
We found that abscess susceptibility depends on sex but is not directly linked to sex chromosomes. B6N females were more susceptible than B6N males, and F1 heterozygous females, from crosses between sensitive and resistant strains, are more susceptible than F1 heterozygous males. Given that E. coli abscess susceptibility is not directly due to alleles on the X, Y, or mitochondrial chromosome, we speculate that hormonal differences control expression of autosomal genes that confer abscess susceptibility. Sex bias has also been observed in Entamoeba histolytica liver abscesses in mice (29–32) and humans (33), where males are more susceptible to liver abscesses than females. In the mouse model, parasites are injected intrahepatically, and orchiectomy reduces abscess formation in males, suggesting a critical role for androgens in abscess susceptibility (30). Elucidating the mechanistic linkages between sex and abscess formation may have broader ramifications for deepening understanding of the well-documented sex differences in human immunity, such as the female bias for autoimmune disorders (34).
In our proposed model for abscess formation, following IV inoculation, E. coli that lodges in the liver stimulates recruitment of innate inflammatory cells that can provoke damage to the hepatic parenchyma, which in turn facilitates replication of E. coli clones (Figure S10). Bacterial replication then leads to recruitment of additional immune cells through positive feedback mechanisms, ultimately leading to abscess formation. Within the framework of our model, the apparent stochasticity in abscess formation in B6J animals can be explained by the observations that B6J mice appear to lie in the phenotypic space in-between resistant (BALB/cJ) and susceptible (B6N) animals; e.g., in CFU and number of replicating clones at 1 dpi, before abscesses have fully formed. Furthermore, we also observed that animals that are more likely to develop abscesses are also more likely to have higher CFU in livers containing abscesses, suggesting that the processes that control likelihood of abscess formation (frequency) may be intertwined with those that control their development (CFU) (Figure S9). Together, these observations suggest that the bimodality in B6J mice is driven by normally distributed immune responses that give rise to zero (resistant) or at least one (susceptible) replicating clones. Therefore, although mice that develop abscesses possess 100,000 times more CFU than mice that do not, the early immunologic events that appear to account for abscess formation may only differ subtly between susceptible and resistant mice, especially if they are the same genotype. We speculate that heightened abscess susceptibility in B6N mice is due to an increase in collateral damage caused by infiltrating cells, which facilitates the replication of a greater number of clones. Notably, the increase in collateral damage does not appear to cause sepsis or other negative clinical outcomes in B6N mice.
Our study adds E. coli to the few bacteria, including Klebsiella pneumoniae (35, 36) and S. aureus (37–39), that are known to give rise to large macroscopic liver abscesses in mice. However, the pathogenesis of the abscesses caused by these three pathogens appears to differ substantially. In marked contrast to the E. coli abscess model, mice that develop K. pneumoniae abscesses also succumb to infection and have high bacterial burden in other tissues (36, 40), suggesting that pathogen specific virulence factors, such as capsular polysaccharides, are sufficient to counter host defenses in a variety of tissues (41). S. aureus liver abscesses arise in humanized transgenic mice expressing HLA-DR4, owing to the direct stimulation of T cells by bacterial superantigens (37). Furthermore, S. aureus can form abscesses in the kidneys and skin even in wild-type strains of mice (42–44). In humans, E. coli is among the most common bacteria found within liver abscesses (15, 45–47), and understanding the molecular determinants of abscess formation and resolution in the murine model presented here may offer important insights for controlling human infections. Taken together, our study demonstrates that murine E. coli liver abscess provide a unique opportunity to decipher liver-specific innate immune mechanisms.
Methods
Ethics
All animal experiments were conducted in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and the Animal Welfare Act of the United States Department of Agriculture using protocols reviewed and approved by Brigham and Women’s Hospital Committee on Animals (Institutional Animal Care and Use Committee (IACUC) protocol number 2016N000416 and Animal Welfare Assurance of Compliance number A4752-01).
Animal experiments
8–12-week-old mice were used for all experiments. Both sexes are used in this study where indicated. Vendor-acquired mice were C57BL/6J (B6J, The Jackson Laboratory 000664), C57BL/6NJ (B6N, The Jackson Laboratory 005304), CBA/J (The Jackson Laboratory 000656), C3H/HeJ (The Jackson Laboratory 000659), BALB/cJ (The Jackson Laboratory 000651), CB6F1/J (The Jackson Laboratory 100007), and B6(Cg)-Tlr4tm1.2Karp/J (TLR4KO, The Jackson Laboratory 029015). Other F1 hybrids (BALB/cJ x B6J, BALB/cJ x B6N) and TLR4KO/TLR4Het were bred at Brigham and Women’s Hospital. Animals were maintained at 68–75°C with 50% humidity in 12 hour day-night cycles.
For infections, defined volumes of frozen CHS7-STAMP library (14), Nissle, or MG1655 derived from overnight cultures were thawed, diluted in PBS, and immediately used to inoculate mice. For intravenous injections, animals were restrained using a Broome-style restrainer (Plas-Labs) and inoculated via the lateral tail vein with 100µl using a 27G needle. A heating pad was used to facilitate dilation of the tail vein. For intraperitoneal injections, animals were inoculated with 100µl into the abdominal cavity with a 27G needle. Gr-1 antibody (ThermoFisher 14-5931-85) was administered (100µg dose) by intraperitoneal injection 1 day prior to inoculation. At indicated times, animals were euthanized by isoflurane inhalation and cervical dislocation or cardiac bleed (when appropriate). To quantify CFU, organs were excised and homogenized with 2 × 2.3 mm stainless steel beads for 2 minutes with a bead beater (BioSpec). Organs were plated and diluted on LB + Kanamycin (for CHS7) or LB (for MG1655 and Nissle) plates.
STAMPR analysis
Analysis of barcode frequency was performed as previously described (13, 14). Liver homogenates were plated as lawns and bacteria were scraped and diluted in PBS+25% glycerol and stored at −80°C. To amplify the barcode locus, samples were thawed and diluted in water and used as template for PCR (25 cycles). Amplicons were verified by agarose gel electrophoresis, pooled, column purified (GeneJet PCR Purification Kit), and sequenced on a MiSeq (Illumina) as 1×78 nt reads. Reads were trimmed and mapped to a defined list of barcodes in CLC Genomics Workbench (Qiagen). Read counts were exported and custom R scripts were used to visualize barcode frequencies and calculate founding population and genetic distance. In Figure 8, all FP and CFUs are reported for ¼ of the liver, which were homogenized in a total of 4 ml but only 1 ml was plated and scraped for STAMPR analysis.
Backcross experiment and analysis
CB6F1 females were crossed with C57Bl/6J males. On weaning, male offspring were genotyped using the Transnetyx Genetic Monitoring service. Male N1s were infected at 9–12 weeks of age and CFU and abscess formation was assessed in the liver at 5 days post infection. Of the ~10,000 SNPs that are genotyped, ~3,000 distinguish BALB/cJ and B6J. Genotyping data was first converted to binary heterozygous (0) or homozygous (1) calls. Since there is only one copy of the X chromosome in male N1s, the BALB/cJ allele was treated as heterozygous (0), and the B6J allele was treated as homozygous (1). For every SNP, mice were separated into homozygous or heterozygous bins, and the abscess frequency within each bin was calculated. The abscess frequency in the homozygous bin relative to the abscess frequency in the heterozygous bin is the Y-axis in Figure S6.
To validate the binning approach described above, animals were also monitored for coat color, which is governed by the agouti locus in Chromosome 2; in N1 males, heterozygous mice have brown coats, and homozygous mice have black coats. We separated mice at every SNP into bins as described above and calculated “black coat frequency” in each group. As expected, when binning near the agouti locus in Chromosome 2, 100% of mice in the homozygous bin have black coats, and 0% of mice in the heterozygous bin have black coats, confirming the validity of our approach at detecting monogenic traits. To avoid dividing by 0, we assume that 0.5 mice in the heterozygous bin had a black coat, yielding a log2 fold change of ~8. Importantly, a 50% penetrant monogenic trait would be expected to have a log2 fold change of ~7 with our sample size (153 mice). Since abscesses are ~70% penetrant in inbred B6J males, a peak would have been evident if the trait was monogenic.
Flow cytometry
To obtain liver cell suspensions, livers were excised and minced with scissors in HBSS + 10 mM EDTA in a 50 ml conical tube. Tissue was then washed 3x with 50 ml PBS to remove EDTA. After the tissue settled to the bottom of the tube, PBS was carefully removed and replaced with 10ml DMEM containing 0.2 mg/ml DNase (Roche 10104159001) and 1 mg/ml Collagenase (Sigma-Aldrich C5138). Tissue was then incubated for 30 minutes at 37°C and passed through a 70µm filter. Additional DMEM washes and mechanical force with a syringe plunger were used to propel cells stuck on the filter through. Cells were centrifuged at 50xg for 5 minutes to spin down hepatocytes, and supernatants, enriched for nonparenchymal cells, were placed in a new 50 ml conical tube. These cells were centrifuged at 500xg for 5 minutes, washed with 10ml of PBS, transferred to a 15 ml conical tube, and centrifuged at 500xg for 5 minutes. The supernatant was removed and 1 ml of red blood cell lysis buffer (Roche 11814389001) was added and cells were incubated for 1 minute, after which 10 ml of PBS was added. Cells were centrifuged at 500xg for 5 minutes and resuspended in 2ml of PBS. To prepare a Percoll gradient, a long Pasteur pipette was used to introduce Percoll to the bottom of the cell suspension. 2ml of 40% Percoll (prepared in HBSS and diluted in DMEM) was added, followed by 2 ml of 80% Percoll. The gradient was centrifuged for 1300xg for 20 minutes. Cells between the 80% and 40% layers were carefully removed and washed in 10 ml of PBS. The cells were then resuspended in 1ml of PBS with 2mM EDTA and 2% FBS. Antibodies (anti-CD45 [Biolegend 103129] and anti-Gr1 [Invitrogen 53-5931-82]) were added to cell suspensions at 1:200 dilutions and incubated at 4°C for 30 minutes. Cells were centrifuged and resuspended in 200µl of PBS with 2mM EDTA and 2% FBS. Flow cytometry was performed with an SH100 Cell Sorter (Sony Biotech) and analyzed with FlowJo.
Cytokine and ALT measurements
Blood was collected via cardiac bleed and left to coagulate in 1.5 ml tubes at room temperature. Serum was retrieved following centrifugation at 2,000xg for 10 minutes at 4°C. ALT was measured with the Alanine Transaminase Colorimetric Activity Assay Kit (Cayman Chemical 700260) according to the manufacturer’s instructions. Cytokines were measured by multiplexed bead-based protein capture (EveTechnologies)
Histology
Livers were embedded in a 30% sucrose:OCT (1:2.5) solution, frozen immediately, and stored at −80°C. Hematoxylin and eosin staining was performed at the Harvard Rodent Histopathology Core facility. Slides were imaged with an Eclipse Ti microscope.
Single-cell RNA sequencing
Mice were infected as described above and euthanized 4 hours post inoculation. Livers were processed as above for flow cytometry, but without DNAse and Percoll to minimize preparation time. Cells were sorted by CD45 expression into PBS + 2% FBS. Cells were processed using the Chromium Next GEM Single Cell 3’ Reagent Kits (10x genomics) and sequenced on a NovaSeq 6000 (Illumina) at the Harvard Medical School Biopolymers Core Facility as 28 (read 1) and 90 (read 2) nt reads.
Reads were processed with 10X Genomics Cloud Analysis to generate hdf5 files and further analysis was performed with Seurat v4.3 (48). Data were filtered by nFeature_RNA > 200, nCount_RNA > 1000, and percent.mt < 80 and normalized with SCTransform. RunPCA and RunUMAP were used prior to doublet removal with DoubletFinder (pN = 0.25, pK = 0.09). Data were the integrated with FindIntegrationAnchors and IntegrateData, after which PCA (RunPCA), cluster identification (FindNeighbors, dims = 1:15, and FindClusters), and UMAP (RunUMAP, reduction “pca”, n.neihbors = 20, min.dist = 0.3, spread = 1, metric = “Euclidean”) was performed. Data displayed in Figure 6 and Figure S8 are SCT transformed.
Spatially resolved transcriptomics
Spatial transcriptomics were performed using MERSCOPE (Vizgen). Livers were embedded in a 30% sucrose:OCT (1:2.5) solution, frozen immediately, and stored at −80°C. Blocks were cut to 10µm sections with a CM1860 UV cryostat (Leica) on to MERSCOPE slides, which contain fluorescent beads for autofocusing on the MERSCOPE instrument. The slides were fixed in 4% paraformaldehyde in PBS (Fixation Buffer) for 15 minutes and washed 3x in PBS and then incubated with 70% ethanol at 4°C overnight.
Permeabilized sections were stained for cell boundaries with the Cell Boundary Staining Kit (Vizgen 10400009). Briefly, slides were washed once in PBS and incubated for 1 hour with Blocking Solution at room temperature. Slides were then incubated with Primary Staining Solution for 1 hour at room temperature. After 3 washes with PBS, slides were incubated with Secondary Staining Solution for 1 hour at room temperature. Slides were then washed 3x in PBS, incubated with Fixation Buffer for 15 minutes, and washed 2x with PBS. To hybridize probes, slides were first washed with Sample Prep Wash Buffer and incubated in Formamide Wash Buffer for 30 minutes at 37°C. 50µl of the MERSCOPE gene panel, a pre-defined panel that targets 140 genes (Table S1), was added to the tissue section, and incubated for two days at 37°C in a humidified chamber. Slides were then washed 2x for 30 minutes each in Formamide Wash Buffer at 47°C, and 1x in Sample Prep Wash Buffer.
Sections were then embedded in a thin gel consisting of a Gel Embedding Premix, 0.05% ammonium persulfate, and 0.005% N,N tetramethylethylenediamine. Gel-embedded slides were cleared by incubating in a Clearing Solution containing 1% Proteinase K at 37°C for three days at 37°C. Cleared sections were then imaged with the MERSCOPE instrument. Data was visualized and analyzed with the MERSCOPE Visualizer.
Supplementary Material
Importance.
Animal models of disseminating bacterial infections are critical for developing therapeutic interventions. Following systemic dissemination in mice, E. coli undergo dramatic replication within abscesses in the liver but not in other organs. Although liver abscesses are the largest reservoir of bacteria within the animal, the processes that lead to abscess formation are not known. Here, we characterize E. coli liver abscess formation and identify several determinants of abscess susceptibility, including sex, mouse genotype, and innate immune factors. By combining spatial and single-cell transcriptomics with genetic and phenotypic analyses, we delineate critical host pathways that underlie abscess formation. Our findings define several avenues for future studies to unravel how abscess susceptibility determinants interact to modulate clearance of systemic infections and govern tissue-specific bacterial replication.
Acknowledgements
This work is supported by NIH F31 AI156949 (K.H.), NIH R01 AI042347 (M.K.W.), and the Howard Hughes Medical Institute (M.K.W.). We are grateful to Caitlyn Holmes, Aric Brown, and members of the Waldor Lab for feedback on this manuscript, and to Jonathan Kagan for valuable discussion and advice. The Harvard Rodent Histopathology and Harvard Biopolymers core facilities supported this work.
Footnotes
Data Availability
Single Cell RNA Sequencing (PRJNA945406) reads have been deposited in the Sequencing Read Archive (SRA).
References
- 1.Diekema DJ, Hsueh P-R, Mendes RE, Pfaller MA, Rolston K V, Sader HS, Jones RN. 2019. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Christaki E, Giamarellos-Bourboulis EJ. 2014. The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host. Virulence 5:57–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Murray CJ, Shunji Ikuta K, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC, Browne AJ, Give Chipeta M, Fell F, Hackett S, Haines-Woodhouse G, Kashef Hamadani BH, P Kumaran EA, McManigal B, Agarwal R, Akech S, Albertson S, Amuasi J, Andrews J, Aravkin A, Ashley E, Bailey F, Baker S, Basnyat B, Bekker A, Bender R, Bethou A, Bielicki J, Boonkasidecha S, Bukosia J, Carvalheiro C, Castañeda-Orjuela C, Chansamouth V, Chaurasia S, Chiurchiù S, Chowdhury F, Cook AJ, Cooper B, Cressey TR, Criollo-Mora E, Cunningham M, Darboe S, J Day NP, De Luca M, Dokova K, Dramowski A, Dunachie SJ, Eckmanns T, Eibach D, Emami A, Feasey N, Fisher-Pearson N, Forrest K, Garrett D, Gastmeier P, Zergaw Giref A, Claire Greer R, Gupta V, Haller S, Haselbeck A, Hay SI, Holm M, Hopkins S, Iregbu KC, Jacobs J, Jarovsky D, Javanmardi F, Khorana M, Kissoon N, Kobeissi E, Kostyanev T, Krapp F, Krumkamp R, Kumar A, Hmwe Kyu H, Lim C, Limmathurotsakul D, James Loftus M, Lunn M, Ma J, Mturi N, Munera-Huertas T, Musicha P, Marcia Mussi-Pinhata M, Nakamura T, Nanavati R, Nangia S, Newton P, Ngoun C, Novotney A, Nwakanma D, Obiero CW, Olivas-Martinez A, Olliaro P, Ooko E, Ortiz-Brizuela E, Yariv Peleg A, Perrone C, Plakkal N, Ponce-de-Leon A, Raad M, Ramdin T, Riddell A, Roberts T, Victoria Robotham J, Roca A, Rudd KE, Russell N, Schnall J, Anthony Gerard Scott J, Shivamallappa M, Sifuentes-Osornio J, Steenkeste N, James Stewardson A, Stoeva T, Tasak N, Thaiprakong A, Thwaites G, Turner C, Turner P, Rogier van Doorn H, Velaphi S, Vongpradith A, Vu H, Walsh T, Waner S, Wangrangsimakul T, Wozniak T, Zheng P, Sartorius B, Lopez AD, Stergachis A, Moore C, Dolecek C, Naghavi M, Antimicrobial Resistance Collaborators. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 0. [Google Scholar]
- 4.Kern W V, Rieg S. 2020. Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect 26:151–157. [DOI] [PubMed] [Google Scholar]
- 5.Frick-Cheng AE, Sintsova A, Smith SN, Pirani A, Snitkin ES, Mobley HLT. 2022. Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli. mBio 13:e0103522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Shea AE, Marzoa J, Himpsl SD, Smith SN, Zhao L, Tran L, Mobley HLT. 2020. Escherichia coli CFT073 fitness factors during urinary tract infection: Identification using an ordered transposon library. Appl Environ Microbiol 86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ. 2016. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis. mBio 7:e00104–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Anderson MT, Brown AN, Pirani A, Smith SN, Photenhauer AL, Sun Y, Snitkin ES, Bachman MA, Mobley HLT. 2021. Replication Dynamics for Six Gram-Negative Bacterial Species during Bloodstream Infection. mBio 12:e0111421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gawish R, Maier B, Obermayer G, Watzenboeck ML, Gorki A-D, Quattrone F, Farhat A, Lakovits K, Hladik A, Korosec A, Alimohammadi A, Mesteri I, Oberndorfer F, Oakley F, Brain J, Boon L, Lang I, Binder CJ, Knapp S. 2022. A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4. Elife 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Michels KR, Lambrecht NJ, Carson WF, Schaller MA, Lukacs NW, Bermick JR. 2019. The Role of Iron in the Susceptibility of Neonatal Mice to Escherichia coli K1 Sepsis. J Infect Dis 220:1219–1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Smith SN, Hagan EC, Lane MC, Mobley HLT. 2010. Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. mBio 1:e00262–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Subashchandrabose S, Smith SN, Spurbeck RR, Kole MM, Mobley HLT. 2013. Genome-Wide Detection of Fitness Genes in Uropathogenic Escherichia coli during Systemic Infection. PLoS Pathog 9:e1003788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hullahalli K, Pritchard JR, Waldor MK. 2021. Refined Quantification of Infection Bottlenecks and Pathogen Dissemination with STAMPR. mSystems 6:e00887–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hullahalli K, Waldor MK. 2021. Pathogen clonal expansion underlies multiorgan dissemination and organ-specific outcomes during murine systemic infection. Elife 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Meddings L, Myers RP, Hubbard J, Shaheen AA, Laupland KB, Dixon E, Coffin C, Kaplan GG. 2010. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol 105:117–124. [DOI] [PubMed] [Google Scholar]
- 16.Welch RA, Burland V, Plunkett G, Redford P, Roesch P, Rasko D, Buckles EL, Liou S-R, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HLT, Donnenberg MS, Blattner FR. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99:17020–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kernbauer E, Maier V, Rauch I, Müller M, Decker T. 2013. Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes. PLoS One 8:e65007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Simon MM, Greenaway S, White JK, Fuchs H, Gailus-Durner V, Wells S, Sorg T, Wong K, Bedu E, Cartwright EJ, Dacquin R, Djebali S, Estabel J, Graw J, Ingham NJ, Jackson IJ, Lengeling A, Mandillo S, Marve J, Meziane H, Preitner F, Puk O, Roux M, Adams DJ, Atkins S, Ayadi A, Becker L, Blake A, Brooker D, Cater H, Champy MF, Combe R, Danecek P, Di Fenza A, Gates H, Gerdin AK, Golini E, Hancock JM, Hans W, Hölter SM, Hough T, Jurdic P, Keane TM, Morgan H, Müller W, Neff F, Nicholson G, Pasche B, Roberson LA, Rozman J, Sanderson M, Santos L, Selloum M, Shannon C, Southwel A, Tocchini-Valentini GP, Vancollie VE, Westerberg H, Wurst W, Zi M, Yalcin B, Ramirez-Solis R, Steel KP, Mallon AM, De Angelis MH, Herault Y, Brown SDM. 2013. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol 14:1–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sonnenborn U. 2016. Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties. FEMS Microbiol Lett 363. [DOI] [PubMed] [Google Scholar]
- 20.Chen KH, Boettiger AN, Moffitt JR, Wang S, Zhuang X. 2015. RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells. Science 348:aaa6090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Guilliams M, Bonnardel J, Haest B, Vanderborght B, Wagner C, Remmerie A, Bujko A, Martens L, Thoné T, Browaeys R, De Ponti FF, Vanneste B, Zwicker C, Svedberg FR, Vanhalewyn T, Gonçalves A, Lippens S, Devriendt B, Cox E, Ferrero G, Wittamer V, Willaert A, Kaptein SJF, Neyts J, Dallmeier K, Geldhof P, Casaert S, Deplancke B, Ten Dijke P, Hoorens A, Vanlander A, Berrevoet F, Van Nieuwenhove Y, Saeys Y, Saelens W, Van Vlierberghe H, Devisscher L, Scott CL. 2022. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185:379–396.e38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hullahalli K, Dailey KG, Waldor MK. 2023. Innate immune responses yield tissue-specific bottlenecks that scale with pathogen dose. bioRxiv 543079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83:64–70. [DOI] [PubMed] [Google Scholar]
- 24.Miller SI, Ernst RK, Bader MW. 2005. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3:36–46. [DOI] [PubMed] [Google Scholar]
- 25.McDonald B, Jenne CN, Zhuo L, Kimata K, Kubes P. 2013. Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia. Am J Physiol Gastrointest Liver Physiol 305:G797–806. [DOI] [PubMed] [Google Scholar]
- 26.Tam K, Torres VJ. 2019. Staphylococcus aureus Secreted Toxins and Extracellular Enzymes. Microbiol Spectr 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Tian L, Chen F, Macosko EZ. 2022. The expanding vistas of spatial transcriptomics. Nat Biotechnol 10.1038/s41587-022-01448-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Keys HR, Knouse KA. 2022. Genome-scale CRISPR screening in a single mouse liver. Cell genomics 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lotter H, Jacobs T, Gaworski I, Tannich E. 2006. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect Immun 74:118–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lotter H, Helk E, Bernin H, Jacobs T, Prehn C, Adamski J, González-Roldán N, Holst O, Tannich E. 2013. Testosterone increases susceptibility to amebic liver abscess in mice and mediates inhibition of IFNγ secretion in natural killer T cells. PLoS One 8:e55694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Lotter H, González-Roldán N, Lindner B, Winau F, Isibasi A, Moreno-Lafont M, Ulmer AJ, Holst O, Tannich E, Jacobs T. 2009. Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess. PLoS Pathog 5:e1000434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Seydel KB, Stanley SL. 1998. Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis. Infect Immun 66:2980–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tharmaratnam T, Kumanan T, Iskandar MA, D’Urzo K, Gopee-Ramanan P, Loganathan M, Tabobondung T, Tabobondung TA, Sivagurunathan S, Patel M, Tobbia I. 2020. Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: a public health problem. Trop Med Health 48:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Billi AC, Kahlenberg JM, Gudjonsson JE. 2019. Sex bias in autoimmunity. Curr Opin Rheumatol 31:53–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lin Y-T, Tseng K-Y, Yeh Y-C, Yang F-C, Fung C-P, Chen N-J. 2014. TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice. Infect Immun 82:1335–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tu Y-C, Lu M-C, Chiang M-K, Huang S-P, Peng H-L, Chang H-Y, Jan M-S, Lai Y-C. 2009. Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model. Infect Immun 77:2657–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tuffs SW, Goncheva MI, Xu SX, Craig HC, Kasper KJ, Choi J, Flannagan RS, Kerfoot SM, Heinrichs DE, McCormick JK. 2022. Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma production. Proc Natl Acad Sci U S A 119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Xu SX, Gilmore KJ, Szabo PA, Zeppa JJ, Baroja ML, Haeryfar SMM, McCormick JK. 2014. Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect Immun 82:3588–3598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hamamoto H, Panthee S, Paudel A, Ohgi S, Suzuki Y, Makimura K, Sekimizu K. 2022. Transcriptome change of Staphylococcus aureus in infected mouse liver. Commun Biol 5:721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fung C-P, Chang F-Y, Lin J-C, Ho DM-T, Chen C-T, Chen J-H, Yeh K-M, Chen T-L, Lin Y-T, Siu LK. 2011. Immune response and pathophysiological features of Klebsiella pneumoniae liver abscesses in an animal model. Lab Invest 91:1029–39. [DOI] [PubMed] [Google Scholar]
- 41.Holmes CL, Wilcox AE, Forsyth V, Smith SN, Moricz BS, Unverdorben L V, Mason S, Wu W, Zhao L, Mobley HLT, Bachman MA. 2023. Klebsiella pneumoniae causes bacteremia using factors that mediate tissue-specific fitness and resistance to oxidative stress. bioRxiv 2023.02.23.529827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cheng AG, DeDent AC, Schneewind O, Missiakas D. 2011. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol 19:225–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Guiberson ER, Weiss A, Ryan DJ, Monteith AJ, Sharman K, Gutierrez DB, Perry WJ, Caprioli RM, Skaar EP, Spraggins JM. 2021. Spatially Targeted Proteomics of the Host-Pathogen Interface during Staphylococcal Abscess Formation. ACS Infect Dis 7:101–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Mohammad M, Na M, Hu Z, Nguyen M-T, Kopparapu PK, Jarneborn A, Karlsson A, Ali A, Pullerits R, Götz F, Jin T. 2021. Staphylococcus aureus lipoproteins promote abscess formation in mice, shielding bacteria from immune killing. Commun Biol 4:432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Wang W-J, Tao Z, Wu H-L. 2018. Etiology and clinical manifestations of bacterial liver abscess: A study of 102 cases. Medicine 97:e12326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Rahimian J, Wilson T, Oram V, Holzman RS. 2004. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 39:1654–9. [DOI] [PubMed] [Google Scholar]
- 47.Serraino C, Elia C, Bracco C, Rinaldi G, Pomero F, Silvestri A, Melchio R, Fenoglio LM. 2018. Characteristics and management of pyogenic liver abscess: A European experience. Medicine 97:e0628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R. 2021. Integrated analysis of multimodal single-cell data. Cell 184:3573–3587.e29. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.